Favourites   Have ideas?  Sign in / Register

Positive:   RNA ↓10.74   Disease: Ear/Nose ↓7.54   Women Health ↓7.14 «See more»   Country: Greate Britain ↑13.33   Immunology ↑14.64   Blood ↑33.9

Negative:   Bad infrastructure  ↑2.21


Gene and cell segment

ABEO Abeona Therapeutics Inc. - Common Stock 0 + Gene and cell, Medicine

+ My List
AGTC Applied Genetic Technologies Corporation - Common Stock -3.85% up -7.41% 3.56 + Medicine, Gene and cell

+ My List
AKUS Akouos, Inc. - Common Stock -8.16% -8.16% 0 + Gene and cell, Disease: Ear/Nose, Medicine

+ My List
ALLO Allogene Therapeutics, Inc. - Common Stock 4.34% up -11.24% 15.58 + Cancer fight, Gene and cell, Medicine

+ My List
APDN Applied DNA Sciences, Inc. - Common Stock -3.45% down 16.38% -19.83 + Medicine, Gene and cell

+ My List
ATHX Athersys, Inc. - Common Stock up -7.92% 7.92 + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's

+ My List
AUTL Autolus Therapeutics plc - American Depositary Shares 13.33% 13.33% 0 + Country: Greate Britain, Gene and cell, Cancer fight, Medicine


Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6 https://t.co/Bswi1mwqgf
+ My List
AVRO AVROBIO, Inc. - Common Stock 0.97% up -7.69% 8.66 + Gene and cell, Pain fight, Medicine

+ My List
AVXL Anavex Life Sciences Corp. - Common Stock -3.22% down 8.33% -11.55 + Gene and cell, Disease: Neurology/Alzheimer/Parkinson's, Medicine

+ My List
BBIO BridgeBio Pharma, Inc. - Common Stock -1.66% -1.66% 0 + Gene and cell


Last highlighted: $BBIO 📜 SEC Form 8-K filed https://t.co/oef6IdAzjQ #majorpharmaceuticals #healthcare
+ My List
BNGO Bionano Genomics, Inc. - Common Stock 6.71% down 14.18% -7.47 + Medicine, Cancer fight, Gene and cell


Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i
+ My List
BNGOW Bionano Genomics, Inc. - Warrant 0 + Cancer fight, Medicine, Gene and cell

+ My List
BNTC Benitec Biopharma Inc. - Common Stock -10.74% -10.74% 0 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell


Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q
+ My List
CABA Cabaletta Bio, Inc. - Common Stock 23.49% 23.49% 0 + Gene and cell, Medicine, Immunology

+ My List
CDXS Codexis, Inc. - Common Stock 1.39% down 11.26% -9.87 + Medicine, Gene and cell

+ My List
CNTG Centogene N.V. - Common Shares -11.76% down -11.25% -0.51 + Gene and cell, Medicine


Last highlighted: #CNTG SEC report: Centogene N.V. Report of proposed sale of securities
SEC Filing Form 144 filed by Centogene N.V. -- SEC File Number 211084208
+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock 2.21% down 7.75% -5.54 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
DTIL Precision BioSciences, Inc. - Common Stock -2.2% down 8.79% -10.99 + Cancer fight, Gene and cell, Food

+ My List
DYN Dyne Therapeutics, Inc. - Common Stock -6.52% down 11.94% -18.46 + Gene and cell, Medicine


Last highlighted: #DYN SEC report: Dyne Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Dyne Therapeutics, Inc. -- SEC File Number
+ My List
EDIT Editas Medicine, Inc. - Common Stock -2.05% down 11.5% -13.55 + Medicine, Gene and cell


Last highlighted: #EDIT SEC report: Editas Medicine, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Editas Medicine, Inc. -- SEC File Number 211142329
+ My List
EPZM Epizyme, Inc. - Common Stock 0 + Cancer fight, Gene and cell

+ My List
EVLO Evelo Biosciences, Inc. - Common Stock 4.52% down 14.81% -10.29 + Medicine, Gene and cell

+ My List
FHTX Foghorn Therapeutics Inc. - Common Stock 6.26% down 11.03% -4.77 + Medicine, Gene and cell


Last highlighted: #FHTX SEC report: Foghorn Therapeutics Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Foghorn Therapeutics Inc. -- SEC File Number 211089297
+ My List
FREQ Frequency Therapeutics, Inc. - Common Stock -6.92% -6.92% 0 + Medicine, Disease: Ear/Nose, Gene and cell


Last highlighted: $FREQ 📜 SEC Form 8-K filed by Frequency Therapeutics, Inc. https://t.co/BVOsAkh3ww #majorpharmaceuticals #healthcare
+ My List
FRLN Freeline Therapeutics Holdings plc - ADSs -7.84% -7.84% 0 + Medicine, Biotechnology, Gene and cell

+ My List
FULC Fulcrum Therapeutics, Inc. - Common Stock 0.73% down 9.81% -9.08 + Medicine, Gene and cell


Last highlighted: #FULC SEC report: Fulcrum Therapeutics, Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Fulcrum Therapeutics, Inc. -- SEC File Number 211160928
+ My List
GBIO Generation Bio Co. - Common stock 5.51% down 7.17% -1.66 + Gene and cell, Medicine


Last highlighted: #GBIO SEC report: Generation Bio Co. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Generation Bio Co. -- SEC File Number 211089285
+ My List
IGMS IGM Biosciences, Inc. - Common Stock -0.42% down 8.83% -9.25 + Biotechnology, Gene and cell, Medicine


Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number
+ My List
ILMN Illumina, Inc. - Common Stock -6.04% up -20.6% 14.56 + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health


Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268
+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock 1.15% down 8.46% -7.31 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
LRMR Larimar Therapeutics, Inc. - Common Stock -0.78% up -7.91% 7.13 + Medicine, Gene and cell, Biotechnology

+ My List
MBIO Mustang Bio, Inc. - Common Stock 0 + Medicine, Gene and cell


Last highlighted: $MBIO 📜 SEC Form 8-K filed by Mustang Bio, Inc. https://t.co/rBa024MAHc #healthcare #majorpharmaceuticals
+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock 33.9% 33.9% 0 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MYGN Myriad Genetics, Inc. - Common Stock -4.27% up -7.38% 3.11 + Gene and cell, Medicine, Women Health


Last highlighted: $MYGN SEC Filing: 8-K Earnings - MYRIAD GENETICS INC (0000899923) August 03 https://t.co/GlGu9uVj6k
+ My List
NBSE NeuBase Therapeutics, Inc. - Common Stock down 8% -8 + Medicine, Gene and cell


Last highlighted: #NBSE SEC report: NeuBase Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by NeuBase Therapeutics, Inc. -- SEC File Number 211078875
+ My List
NTLA Intellia Therapeutics, Inc. - Common Stock -4.32% down 10.42% -14.74 + Medicine, Gene and cell, Biotechnology, Biopharma

+ My List
ORGS Orgenesis Inc. - Common Stock -8.26% -8.26% 0 + Biotechnology, Medicine, Gene and cell


Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk
+ My List
ORTX Orchard Therapeutics plc - American Depositary Shares 0 + Medicine, Gene and cell


Last highlighted: #ORTX SEC report: Orchard Therapeutics plc Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Orchard Therapeutics plc -- SEC File Number 211142307
+ My List
PASG Passage Bio, Inc. - Common Stock -1.67% down 8.09% -9.76 + Gene and cell, Medicine


Last highlighted: #PASG SEC report: Passage BIO, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by Passage BIO, Inc. -- SEC File Number 211102754
+ My List
PGEN Precigen, Inc. - Common Stock -5.19% down 8% -13.19 + Biopharma, Gene and cell, Medicine


Last highlighted: #PGEN SEC report: PRECIGEN, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PRECIGEN, INC. -- SEC File Number
+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock 4.38% down 12.62% -8.24 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine


Last highlighted: Research Analysts Set Expectations for Praxis Precision Medicines, Inc.’s Q1 2022 Earnings $PRAX https://t.co/u6zv6m9Tyz #markets
+ My List
PROG Progenity, Inc. - Common Stock -10% -10% 0 + Gene and cell, Medicine, Cancer fight, Women Health


Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number
+ My List
PSTX Poseida Therapeutics, Inc. - Common Stock 0.46% down 10.55% -10.09 + Medicine, Gene and cell


Last highlighted: #PSTX SEC report: Poseida Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Poseida Therapeutics, Inc. -- SEC File Number
+ My List
RGNX REGENXBIO Inc. - Common Stock -7.44% -7.44% 0 + Gene and cell, Biotechnology, Medicine

+ My List
RNA Avidity Biosciences, Inc. - Common Stock -10.19% -10.19% 0 + Medicine, Gene and cell


Last highlighted: #RNA SEC report: Avidity Biosciences, Inc. Prospectus [Rule 424(b)(5)]
SEC Filing Form 424B5 filed by Avidity Biosciences, Inc. -- SEC File Number 211136619
+ My List
RUBY Rubius Therapeutics, Inc. - Common Stock -13.51% -13.51% 0 + Gene and cell, Cancer fight, Medicine

+ My List
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock -0.86% up -8.49% 7.63 + Pharmaceutical , Gene and cell, Medicine


Last highlighted: #RYTM SEC report: RHYTHM PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by RHYTHM PHARMACEUTICALS, INC. -- SEC File Number 211137945
+ My List
SYRS Syros Pharmaceuticals, Inc. - common stock up -16.83% 16.83 + Gene and cell, Medicine, Cancer fight

+ My List
TSHA Taysha Gene Therapies, Inc. - Common Stock -8.22% -8.22% 0 + Gene and cell, Disease: Central nervous system (CNS), Medicine

+ My List
XCUR Exicure, Inc. - Common Stock 0 + Gene and cell, Medicine


Last highlighted: $XCUR 8-K Exicure (12 May, 4:13pm) 📰 Exicure, Inc. Reports First Quarter 2021 Financial Results and Corporate Progress https://t.co/VEYCSavonT #XCUR #8K #Exicure #News
+ My List
FDMT 4D Molecular Therapeutics, Inc. - Common Stock -5.58% up -8.25% 2.67 + Medicine, Gene and cell, Disease: Eye

+ My List
LGVN Longeveron Inc. - common stock 16.48% 16.48% 0 + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.